When Troponin is Positive but the Diagnosis Is Not: Diagnostic Pitfalls and a Mechanism-Based Approach in Hospitalized Patients

High-sensitivity cardiac troponin (hs-cTn) assays have increased detection of myocardial injury in hospitalized patients, but clinical practice has not fully adapted to the distinction between biomarker positivity and myocardial infarction (MI). In medically complex inpatients, troponin elevation commonly reflects myocardial injury or type 2 MI rather than acute coronary thrombosis. As a result, reflexive labeling as MI can trigger antithrombotic therapy, low-yield invasive testing, and durable diagnostic labels that shape downstream care. This narrative review synthesizes contemporary consensus definitions, guideline statements, and peer-reviewed clinical studies relevant to hs-cTn interpretation in hospitalized and critically ill adults. Emphasis is placed on classification, inpatient diagnostic pitfalls, management patterns, and downstream consequences of misclassification, including common inpatient contexts such as sepsis, perioperative illness, tachyarrhythmias, and chronic kidney disease. Across inpatient cohorts, hs-cTn elevation is frequent, whereas adjudicated type 1 MI represents a minority of abnormal results. Mechanisms of troponin release extend beyond plaque rupture and include inflammatory signaling, membrane permeability changes, apoptosis, and mechanical stretch in overlapping physiologic stressors. Observational studies suggest that diagnostic labeling influences care trajectories, with higher rates of coronary angiography and secondary prevention therapy without clear long-term mortality benefit. In addition, cognitive heuristics, indiscriminate testing, and incomplete clinical context contribute to diagnostic momentum. Accordingly, hs-cTn elevation should be interpreted using a probability-driven, mechanism-based framework that requires ischemic corroboration to diagnose MI, uses serial change to determine acuity rather than mechanism, prioritizes identification and treatment of reversible stressors, and escalates to imaging or invasive evaluation selectively when ischemic suspicion remains high.

Authors

Institutions

Publication Details

Journal
Journal of Community Hospital Internal Medicine Perspectives
Published
2026-11-17
DOI
https://doi.org/10.55729/2000-9666.1665
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

When Troponin is Positive but the Diagnosis Is Not: Diagnostic Pitfalls and a Mechanism-Based Approach in Hospitalized Patients

Fahd Nazir, Syed Sami N Zafar Ahmed, Zahed Barak, Babar Ali
Journal of Community Hospital Internal Medicine Perspectives
Acute Myocardial Infarction Research
article

When Troponin is Positive but the Diagnosis Is Not: Diagnostic Pitfalls and a Mechanism-Based Approach in Hospitalized Patients

Fahd Nazir, Syed Sami N Zafar Ahmed, Zahed Barak, Babar Ali
article en

Abstract

High-sensitivity cardiac troponin (hs-cTn) assays have increased detection of myocardial injury in hospitalized patients, but clinical practice has not fully adapted to the distinction between biomarker positivity and myocardial infarction (MI). In medically complex inpatients, troponin elevation commonly reflects myocardial injury or type 2 MI rather than acute coronary thrombosis. As a result, reflexive labeling as MI can trigger antithrombotic therapy, low-yield invasive testing, and durable diagnostic labels that shape downstream care. This narrative review synthesizes contemporary consensus definitions, guideline statements, and peer-reviewed clinical studies relevant to hs-cTn interpretation in hospitalized and critically ill adults. Emphasis is placed on classification, inpatient diagnostic pitfalls, management patterns, and downstream consequences of misclassification, including common inpatient contexts such as sepsis, perioperative illness, tachyarrhythmias, and chronic kidney disease. Across inpatient cohorts, hs-cTn elevation is frequent, whereas adjudicated type 1 MI represents a minority of abnormal results. Mechanisms of troponin release extend beyond plaque rupture and include inflammatory signaling, membrane permeability changes, apoptosis, and mechanical stretch in overlapping physiologic stressors. Observational studies suggest that diagnostic labeling influences care trajectories, with higher rates of coronary angiography and secondary prevention therapy without clear long-term mortality benefit. In addition, cognitive heuristics, indiscriminate testing, and incomplete clinical context contribute to diagnostic momentum. Accordingly, hs-cTn elevation should be interpreted using a probability-driven, mechanism-based framework that requires ischemic corroboration to diagnose MI, uses serial change to determine acuity rather than mechanism, prioritizes identification and treatment of reversible stressors, and escalates to imaging or invasive evaluation selectively when ischemic suspicion remains high.

Journal of Community Hospital Internal Medicine PerspectivesVol. 16(6)
Touro College (US), Oldham Council (GB)
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon